← Open Payments lookup

ALLYSA SAGGESE: Open Payments

NPI 1912448846 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$44,404 in 121 payments from 15 companies in 2025. Trend: 2023 $606 · 2024 $2,862 · 2025 $44,404

Speaker / faculty: $16,783Consulting: $15,950Food & beverage: $6,013Travel & lodging: $5,658
CompanyPaymentsAmount
Ipsen Biopharmaceuticals, Inc28$22,667
Madrigal Pharmaceuticals40$12,425
Gilead Sciences, Inc.25$4,641
Novo Nordisk Inc5$2,447
Mirum Pharmaceuticals, Inc.5$1,693
Janssen Biotech, Inc.4$162
ABBVIE INC.3$84
Veloxis Pharmaceuticals, Inc.2$68
Takeda Pharmaceuticals U.S.A., Inc.3$54
QOL Medical, LLC1$47

Products named: IQIRVO, REZDIFFRA, Livdelzi, Wegovy, Livmarli, TREMFYA, Vemlidy, ENVARSUS.

Industry payments across NY — which companies pay providers there.